1 / 34

AIDS – Acquired Immune Deficiency Syndrome

AIDS – Acquired Immune Deficiency Syndrome. A syndrome of opportunistic infections that occur as the final stage of infection by the human immunodeficiency virus (HIV) Destruction & progressive loss of the immune function Can affect any organ First identified in 1981. AIDS Spectrum.

Télécharger la présentation

AIDS – Acquired Immune Deficiency Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. AIDS – Acquired Immune Deficiency Syndrome • A syndrome of opportunistic infections that occur as the final stage of infection by the human immunodeficiency virus (HIV) • Destruction & progressive loss of the immune function • Can affect any organ • First identified in 1981

  2. AIDS Spectrum • Infected individuals that appear healthy • No signs of infection • Chronic Illness • Terminal Stage Disease

  3. AIDS Spectrum • From the time of infection until full blown AIDS can take 1 year to 15 years • May take 6 weeks to a year from time of infection to when a person becomes HIV positive • May pass it on to others • False sense of security

  4. Transmission of AIDS • Transmitted through body fluids • Tears • Saliva • Blood • Sexual Intercourse • Mother’s Breast Milk • Homosexuals, IV drug users/infected needles • Sex with multiple partners • Blood transfusions • Organ transplants

  5. Protection Against AIDS • UNIVERSAL/STANDARD PRECAUTIONS!! • Gown, Gloves, Goggles • Protection from needle sticks • Never recap needles

  6. Opportunistic Infections • Skin lesions • Purplish blotches or bumps on the face & extremities • Pneumonias • Bacterial (H Influenza & Streptococcus) • Viral Infections • Cytomegalovirus most common virus • Effects the lungs and eyes

  7. Opportunistic Infections • Kaposi’s Sarcoma • Cancer of skin spreading to other sites (lungs & GI) • Tuberculosis • Fungal Infections • Mucosal & tongue Candidiasis • Fungal Pneumonias (Pneumocystis Carinii) • Eye infections • Cervical Cancers

  8. Treatment • Supportive Care • Oxygen • Psychological counseling • Anti-viral agents • AZT • Retrovir • Videx • Treat individual infections

  9. Treatment • Pneumocystis Carinii Pneumonia • IV or aerosolized pentamidine • Trade Name: Nebupent • Aerosolized pentamidine associated with less side effects. • Administered is given with Respirgard II nebulizer • Series of 3 one-way valves • Expiratory filter to trap exhaled particles • Particle size needs to be 1-2 microns to deposit in the alveoli

  10. Dosage of pentamidine • Comes in a dry powder • 300 mg vial must be reconstituted with 6 mL of sterile water. • The entire 6 mL is placed in the nebulizer. • Give a bronchodilator before giving the pentamidine. • Given on out-patient basis; 300 mg/once a month.

  11. Environmental Exposure to Healthcare Worker • Risk to Healthcare Workers (HCW) • Exposure to the drug. • Risk of infection with TB often associated with AIDS (airborne transmission). • HCW should be tested periodically for TB. • Nursing and Pregnant women should avoid exposure to the drug.

  12. Environmental Risk of HCW • HCW have developed • Bronchospasm • Conjunctivitis • Need to protect themselves during administration • Gloves, mask and goggles • Stop nebulization if the patient takes the mouthpiece out of their mouth or if they stop to cough.. • Use an isolation booth or hood assembly with an exhaust fan and high efficiency filter.

  13. Lung Abscess • Lung abscess is a necrotizing infection characterized by localized pus • Aspiration of oral and GI fluids containing anaerobic organisms. • Aspiration a result of impaired cough function (unconscious or obtunded from alcohol) • Mouth (between teeth and gums); poor oral hygiene: • Peptostreptococcus sp. • Bacteroides sp. • Fusobacterium sp. • Clostridium sp.

  14. Chest Assessment • Increased tactile and vocal fremitus • Dull percussion note • Crackles/rhonchi • Pleural friction rub • Bronchial breath sounds • Whispered Pectoriloquy • Bronchophony or Egophony

  15. Clinical Assessment • Nonproductive, barking or hacking cough. • Later, cough becomes productive. • Hemoptysis • Purulent • Painful respirations. • Pleural is involved. • Fever & sweats • Weight loss • Periodontal disease

  16. Chest X-ray • Consolidation with single cavity containing an air-fluid level. • Air bronchograms • Pleural effusions • Silhouette sign

  17. Aspiration Pneumonitis • Aspiration of gastric juice with a pH of 2.5 or less causes serious and fatal pneumonia • Acute inflammatory reaction does not usually occur until 12-24 hours after aspiration • Can lead to the development of ARDS • Mendelson’s Syndrome

  18. Lipoid Pneumonitis • Aspiration of oil • Mineral Oils • Oils from animal fat

  19. Avian Flu

  20. Influenza Pandemic • Pandemic vs. Epidemic • Three conditions must be met for an Influenza pandemic to start: • A new influenza virus subtype must emerge for which there is little or no human immunity; • It must infect humans and causes illness; and • It must spread easily and sustainably (continue without interruption) among humans.

  21. Past Influenza Pandemics • 1933: Influenza virus first isolated • 1918-1920: Spanish Flu (H1N1) • Hundreds of millions infected; 50 million deaths (600,000 in US) • Mortality highest in 20- to 40-year age group • 1957: Asian Flu (H2N2) • Million deaths worldwide (80,000 in US) • 1968: Hong Kong Flu (H2N2) • 700,000 deaths (34,000 in US)

  22. Avian Flu • H5N1 virus • Thought to have originated by reassortment between multiple cocirculating avian influenza strains prevalent in Hong Kong in 1997. • Continued evolution since 1997. • Human transmission appears to be associated with close contact with infected poultry. • Plucking • Playing • Cock fights • Drinking raw duck blood

  23. Human-to-Human Transmission • Rare • 15 family clusters involving more than two family members documented between 1/04 & 7/05. • 200 cases worldwide – none in US. • 2006: H5N1 found in Azerbaijan, Cambodia, China, Djibouti, Egypt, Indonesia, Iraq, Thailand, Turkey • http://www.cdc.gov/flu/avian/

  24. Symptoms of Avian Flu • Non-specific complaints of fever. • Cough • Dyspnea • Conjunctivitis • CXR: Diffuse infiltrates; rare pleural effusions. • Lab: Leukopenia

  25. Treatment for Avian Flu • Supportive • Antiviral drugs • amantadine, rimantadine, oseltamivir, and zanamivir • Vaccine • Flu vaccine not effective

  26. Swine Flu http://www.cdc.gov/h1n1flu/key_facts.htm

  27. Severe Acute Respiratory Syndrome (SARS)

  28. SARS Outbreak • Emerged from Southern China • First case reported 11/16/02 • 1/31/03 patient presented to hospital in Guangdong, China. • Transmission to 49 HCWs and 19 family members. • Spread throughout local municipalities. • Carried to Hong Kong by nephrologist attending a wedding. • Transmission to 15 hotel guests (including international travelers) • Outbreaks in Vietnam, Canada, Singapore, & Phillipines

  29. Coronovirus • Novel human coronovirus (SARS-CoV) • Coronaviruses are enveloped RNA viruses. • Some strains well-recognized as causing the common cold. • Transmission to human thought to be associated with the handling (and eating) of the palm civet, ferret badgers, and raccoon dogs.

  30. Epidemiology & Clinical Presentation • Transmission is by inhalation of infected respiratory droplets • Incubation period is 2 to 10 days • Maximum infectivity does not occur at the time of symptom onset (unlike most viruses) • Occurs in 2nd week and at the time of rapid clinical deterioration. • Initial symptoms resemble influenza, with fever, cough, chills, rigor, and myalgia.

  31. Diagnostic Testing • CXR: Usually normal initially • Pulmonary infiltrates as disease progresses • Lab: WBC normal or low

  32. Treatment • Supportive • 70-80% have full recovery • Others develop ARDS-like picture and 50% die • Mechanical Ventilation • Anti-Viral Agents • oseltamivir • ribavirin • ISOLATION! • Protection of healthcare workers. • N-95 masks

More Related